The elevated concentration of circulating leptin has been consistently associated with other cardiometabolic risk factors, such as hypertension, insulin resistance, and type 2 diabetes [11-18]; however, few studies have analyzed its association with metabolic syndrome [7-9]. Here, LEP is linked to metabolic syndrome.